Introduction – Methods – Results Monday afternoon at ASH found me listening to an abstract by Nora Grieb. It was a study from the German Registry for Hematopoietic Stem Cell Transplantation and Cell...
Jim Shoemaker
Diagnosed in 2007 at 59, Jim has had various treatments, including transplant and recently, a clinical trial with Talquetamab. Jim founded the Memphis group and is passionate about supporting the myeloma community. Having a solid support system at home, with his best friend, wife of over 50 years, and care partner, Linda has provided Jim strength when he needed it most. To say she is the “best” would be an understatement.
Jim works full-time & is very involved with his church-Jim shares that exercise, diet, and prayer make a difference. Jim says, “I have been a student of this disease for many years now and I feel God has called me to be a small part in helping others navigate this process and encouraging them to be their best advocates.”
Follow Jim on X: @JimJhs17
Support Group Website: The Memphis/Mid-South Multiple Myeloma Support Group
Learning About ‘Six-Month Resistance Training Interventions’
One of my highlights on Sunday at ASH 2024 was attending the session by Janine Joseph, MS, MBA. The title was, “Six-Month Resistance Training Interventions Are Associated with Improvements in...
My Key Takeaways from ASH 2024
Monday, December 16. Seven days ago, I was in meetings in San Diego overwhelmed and overloaded with information. My experience at ASH in San Diego is difficult to explain. I had the privilege to...
What Do Healthcare Professionals Consider “Frail”?
What Is the CRAB Criteria in Multiple Myeloma?
Meditations on a Scripture
Having been diagnosed 17 years ago with multiple myeloma makes me a survivor, with an understanding that I am not cured of this disease. Yet, I am blessed to have experienced great progress since...